Related Articles
Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long‑acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors
Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo.
Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways
Treatment of liver cancer in mice by the intratumoral injection of an octreotide-based temperature‑sensitive gel
Predominance of precore mutations and clinical significance of basal core promoter mutations in chronic hepatitis B virus infection in Indonesia